Company / Operating Margin
Acadia Pharmaceuticals Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
9.8%
FY2025
5-year range
-43.2% / 24.1%
FY2021-FY2025
Trend
-59.4%
vs FY2024
Sector context
#44 of 135
Health Care
What the data says
At 9.8%, Acadia Pharmaceuticals's operating margin ranks #44 of 135 in the Health Care sector. Operating Margin has fluctuated over the past 10 years, ranging from -1574.1% in FY2016 to 24.1% in FY2024.
Based on SEC 10-K filings.
9.8% in FY2025 with a 5-year CAGR of +74.7%.
Improved from -10.1% to 9.8% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +53.0pp
- 5-Year Change
- +74.7pp
- 10-Year Change
- -
Sector benchmark
#44 of 135 in Health CareTop 33% of 135This company 9.8% Sector average -774.4%
▼
+101.3% above sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 59.4% year-over-year.
- Currently 784.2pp above the Health Care sector average.
- Peak operating margin was recorded in FY2024.
- Lowest operating margin in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 9.8% | -59.4% |
| FY2024 | 24.1% | +338.6% |
| FY2023 | -10.1% | +76.6% |
| FY2022 | -43.2% | -22.8% |
| FY2021 | -35.2% | +45.7% |
| FY2020 | -64.9% | +10.8% |
| FY2019 | -72.7% | +34.2% |
| FY2018 | -110.6% | +52.8% |
| FY2017 | -234.1% | +85.1% |
| FY2016 | -1574.1% | +99.4% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026